Cargando…

Low Programmed Cell Death 5 Expression is a Prognostic Factor in Ovarian Cancer

BACKGROUND: Ovarian cancer is a leading gynecological malignancy. We investigated the prognostic value of programmed cell death 5 (PDCD5) in patients with ovarian cancer. METHODS: Expression levels of PDCD5 mRNA and protein were examined in six ovarian cancer cell lines (SKOV3, CAOV3, ES2, OV1, 3AO,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Li, Ye, Xue, Ma, Rui-Qiong, Cheng, Hong-Yan, Han, Hong-Jing, Cui, Heng, Wei, Li-Hui, Chang, Xiao-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832950/ https://www.ncbi.nlm.nih.gov/pubmed/25881604 http://dx.doi.org/10.4103/0366-6999.155100

Ejemplares similares

Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer
por: Guo, Yan-Xiu, et al.
Publicado: (2018)

Prediction of chemotherapeutic resistance in serous ovarian cancer with low-density custom microarray
por: Zhu, Hong-Lan, et al.
Publicado: (2020)

Prognostic significance of programmed cell death ligand 1 expression in patients with ovarian carcinoma: A systematic review and meta-analysis
por: Huang, Li-Jun, et al.
Publicado: (2018)

Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma
por: Zhu, Jun, et al.
Publicado: (2017)

Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
por: Gao, Yuan, et al.
Publicado: (2017)

Age and menopausal status are important factors influencing the serum human epididymis secretory protein 4 level: a prospective cross-sectional study in healthy Chinese people
por: Cheng, Hong-Yan, et al.
Publicado: (2020)

Programmed Cell Death Tunes Tumor Immunity
por: Liu, Jing, et al.
Publicado: (2022)

Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis
por: Piao, Jinlan, et al.
Publicado: (2020)

Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer
por: Tang, Ying, et al.
Publicado: (2020)

WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells
por: Yu, Hai-Lan, et al.
Publicado: (2019)

Evaluation of Circulating Endometrial Cells as a Biomarker for Endometriosis
por: Chen, Ying, et al.
Publicado: (2017)

Expression and prognostic value of CLIC1 in epithelial ovarian cancer
por: Yu, Wentao, et al.
Publicado: (2018)

Swyer's Syndrome with Mixed Ovarian Malignant Germ Cell Tumor and Ovarian Gonadoblastoma
por: Zhu, Hong-Lan, et al.
Publicado: (2016)

Hypophysitis induced by anti-programmed cell death protein 1 immunotherapy in non-small cell lung cancer: Three case reports
por: Zheng, Yun, et al.
Publicado: (2022)

Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
por: Zhang, Lu, et al.
Publicado: (2021)

Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis
por: Li, Xiao-Song, et al.
Publicado: (2020)

Prognostic implications of PPL expression in ovarian cancer
por: Hua, Tian, et al.
Publicado: (2022)

Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer
por: Zhang, Guo‐Qiang, et al.
Publicado: (2021)

Effects of Previous Laparoscopic Surgical Diagnosis of Endometriosis on Pregnancy Outcomes
por: Li, Hui, et al.
Publicado: (2017)

The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis
por: Li, John Zeng Hong, et al.
Publicado: (2016)

Treatment of liver metastases in patients with epithelial ovarian cancer
por: Deng, Hao, et al.
Publicado: (2021)

Assessing of programmed cell death gene signature for predicting ovarian cancer prognosis and treatment response
por: Lian, Xin, et al.
Publicado: (2023)

Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes
por: Jin, Jing-Lu, et al.
Publicado: (2020)

Overexpression of programmed cell death 5 in a mouse model of ovalbumin-induced allergic asthma
por: Diao, Xiaolin, et al.
Publicado: (2016)

A case of death of patient with ovarian fibroma combined with Meigs Syndrome and literature review
por: Tan, Na, et al.
Publicado: (2022)

Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancer
por: Cheng, Ying, et al.
Publicado: (2021)

Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
por: Chen, Kaiyan, et al.
Publicado: (2016)

MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer
por: Li, Yike, et al.
Publicado: (2022)

Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer
por: Huang, Xuan-zhang, et al.
Publicado: (2020)

Fatal adverse events associated with programmed cell death protein 1 or programmed cell death-ligand 1 monotherapy in cancer
por: Zhao, Bin, et al.
Publicado: (2020)

FOXP4‐AS1 is a favorable prognostic-related enhancer RNA in ovarian cancer
por: Hua, Tian, et al.
Publicado: (2021)

Ovarian cancer‐excreted exosomal miR‐199a‐5p suppresses tumor metastasis by targeting hypoxia‐inducible factor‐2α in hypoxia microenvironment
por: Lian, Xuan‐Ye, et al.
Publicado: (2020)

A Pan-Cancer Analysis of Prognostic and Immunological Roles for Cell Death Genes
por: Hong, Ye, et al.
Publicado: (2023)

Clinical characteristics, treatment status and complications in women with tube ovarian abscess and endometriosis: a retrospective study
por: Li, Hui, et al.
Publicado: (2021)

Identification of Biomarkers for Endometriosis Using Clinical Proteomics
por: Zhao, Yang, et al.
Publicado: (2015)

Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers
por: Zheng, Xiao-Hui, et al.
Publicado: (2014)

Characterization and Prognostic Significance of Cutaneous Adverse Events to Anti-Programmed Cell Death-1 Therapy
por: Lee, Ye Jin, et al.
Publicado: (2019)

The incidence of pseudoprogressive disease associated with programmed cell death 1/programmed cell death ligand 1 inhibitors: A meta-analysis
por: Zhang, Jingyi, et al.
Publicado: (2021)

Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas
por: Yang, Min-Wei, et al.
Publicado: (2019)

Death-associated protein kinase 1 is associated with cognitive dysfunction in major depressive disorder
por: Li, Xiao-Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ah5fnqakg9mh8v7f0darjvcnno